raubasine has been researched along with paynantheine in 1 studies
Studies (raubasine) | Trials (raubasine) | Recent Studies (post-2010) (raubasine) | Studies (paynantheine) | Trials (paynantheine) | Recent Studies (post-2010) (paynantheine) |
---|---|---|---|---|---|
140 | 8 | 22 | 8 | 0 | 7 |
Protein | Taxonomy | raubasine (IC50) | paynantheine (IC50) |
---|---|---|---|
Mu-type opioid receptor | Homo sapiens (human) | 2.2 | |
Kappa-type opioid receptor | Homo sapiens (human) | 10 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Avery, BA; Berthold, EC; Herting, JR; Kamble, SH; King, TI; León, F; McCurdy, CR; McMahon, LR; Popa, R; Raju Kanumuri, SR; Sharma, A | 1 |
1 other study(ies) available for raubasine and paynantheine
Article | Year |
---|---|
Pharmacokinetics of Eleven Kratom Alkaloids Following an Oral Dose of Either Traditional or Commercial Kratom Products in Rats.
Topics: Alkaloids; Animals; Indole Alkaloids; Indoles; Male; Mitragyna; Molecular Structure; Oxindoles; Plant Preparations; Rats; Rats, Sprague-Dawley; Secologanin Tryptamine Alkaloids; Spiro Compounds | 2021 |